Mayo Clinic Platform_Accelerate has announced its latest cohort of health tech startups, including national and international businesses. They will participate in an immersive, 30-week program that offers participants access to expert mentors, industry-leading technologies and millions of de-identified, longitudinal clinical records to develop and validate their artificial intelligence (AI)-driven healthcare solutions.
Participating companies will have unparalleled access to Mayo Clinic experts in regulatory, clinical, technology and business domains along with top investors and healthcare leaders - unlocking the resources, relationships and credibility needed to scale and succeed in their ventures.
"The only way we can transform healthcare is by bringing together clinical experts with technology innovators," says John Halamka, M.D., Diercks president of Mayo Clinic Platform. "Our Accelerate program connects innovative startups with Mayo Clinic physicians and scientists to turn breakthrough ideas into real-world healthcare solutions."
More about each of the companies in the new cohort who are working to tackle some of healthcare's biggest challenges:
- Bowhead Health is developing a radiogenomics platform that uses imaging to predict genomic mutations and guide personalized treatment and clinical trial matching.
- Cleancard is creating an AI-powered, at-home cancer detection test that delivers lab-grade diagnostics in 30 minutes.
- Dart Health rapidly deploys hospital-wide AI solutions by embedding engineering teams on-site to solve clinical and operational challenges.
- Kanjo Health uses AI and evidence-based insights to deliver earlier, personalized and scalable care for children with attention-deficit/hyperactivity disorder (ADHD) and autism.
- Koroid's intelligent platform predicts clinical demand and automates healthcare logistics to utilize staff and resources in an efficient, cost-effective and safe manner leading to better quality care.
- MedLink Global is advancing AI-driven precision psychiatry with tools that deliver accurate diagnoses and personalized treatment guidance.
- MyAtlas Health leverages AI and data from wearable devices to predict mental health crises early and deliver personalized, preventive support.
- Ordinatrum Health enhances critical care through AI-powered, FDA-cleared virtual intensive care units (ICU) and data integration solutions.
- Promed AI combines at-home testing and multimodal AI to deliver affordable, personalized preventive healthcare.
- RTHM provides data-driven, technology-enabled care to improve the diagnosis of and treatment for complex chronic illnesses like long COVID, myalgic encephalomyelitis and chronic fatigue syndrome.
- Radical is developing a general-purpose AI model for oncology that generates personalized treatment recommendations to improve outcomes and reduce costs.
"We're proud to welcome our October cohort - 11 companies pushing the boundaries of AI in healthcare," says Jamie Sundsbak, director of the Accelerate program. "Their energy and vision reflect the very spirit of Accelerate: bold innovation, deep collaboration and a relentless focus on patient impact. Our team is honored to support their journey and excited to see what they build next."
